Inspire Investing LLC Buys New Shares in DENTSPLY SIRONA Inc. $XRAY

Inspire Investing LLC bought a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 3rd quarter, Holdings Channel reports. The firm bought 71,307 shares of the medical instruments supplier’s stock, valued at approximately $632,000.

A number of other hedge funds have also recently made changes to their positions in XRAY. MBL Wealth LLC purchased a new position in DENTSPLY SIRONA during the third quarter valued at $119,000. Skylands Capital LLC boosted its holdings in DENTSPLY SIRONA by 12.6% in the third quarter. Skylands Capital LLC now owns 199,150 shares of the medical instruments supplier’s stock worth $1,764,000 after acquiring an additional 22,300 shares in the last quarter. Great Hill Capital LLC boosted its holdings in DENTSPLY SIRONA by 7.8% in the third quarter. Great Hill Capital LLC now owns 1,749,065 shares of the medical instruments supplier’s stock worth $15,497,000 after acquiring an additional 126,680 shares in the last quarter. IFP Advisors Inc grew its stake in shares of DENTSPLY SIRONA by 244.4% in the third quarter. IFP Advisors Inc now owns 5,566 shares of the medical instruments supplier’s stock worth $49,000 after acquiring an additional 3,950 shares during the last quarter. Finally, Counterpoint Mutual Funds LLC grew its stake in shares of DENTSPLY SIRONA by 178.5% in the third quarter. Counterpoint Mutual Funds LLC now owns 80,715 shares of the medical instruments supplier’s stock worth $715,000 after acquiring an additional 51,738 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently weighed in on XRAY. Leerink Partners reduced their price target on DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating for the company in a report on Wednesday, October 14th. Weiss Ratings reiterated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Monday, August 3rd. Barclays increased their price objective on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a research report on Monday, August 24th. Piper Sandler cut their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research report on Friday, October 9th. Finally, BMO Capital Markets reduced their price objective on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating for the company in a research note on Thursday, September 17th. Three analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $12.62.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $9.53 on Friday. DENTSPLY SIRONA Inc. has a one year low of $8.32 and a one year high of $14.76. The stock has a 50-day moving average of $9.70 and a 200 day moving average of $11.34. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63. The company has a market capitalization of $1.90 billion, a price-to-earnings ratio of -3.47, a PEG ratio of 1.23 and a beta of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.17. The business had revenue of $898.00 million for the quarter, compared to analysts’ expectations of $889.93 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The business’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.52 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.39 EPS for the current year.

About DENTSPLY SIRONA

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.